These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib. Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003 [TBL] [Abstract][Full Text] [Related]
4. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. Ji JH; Oh YL; Hong M; Yun JW; Lee HW; Kim D; Ji Y; Kim DH; Park WY; Shin HT; Kim KM; Ahn MJ; Park K; Sun JM PLoS Genet; 2015 Aug; 11(8):e1005467. PubMed ID: 26295973 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524 [TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of ependymomas reveals 6q loss as the most common aberration. Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel ALK rearrangement A2M-ALK in a neonate with fetal lung interstitial tumor. Onoda T; Kanno M; Sato H; Takahashi N; Izumino H; Ohta H; Emura T; Katoh H; Ohizumi H; Ohtake H; Asao H; Dehner LP; Hill AD; Hayasaka K; Mitsui T Genes Chromosomes Cancer; 2014 Oct; 53(10):865-74. PubMed ID: 24965693 [TBL] [Abstract][Full Text] [Related]
8. SEC31A-ALK Fusion Gene in Lung Adenocarcinoma. Kim RN; Choi YL; Lee MS; Lira ME; Mao M; Mann D; Stahl J; Licon A; Choi SJ; Van Vrancken M; Han J; Wlodarska I; Kim J Cancer Res Treat; 2016 Jan; 48(1):398-402. PubMed ID: 25715771 [TBL] [Abstract][Full Text] [Related]
9. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors. Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628 [TBL] [Abstract][Full Text] [Related]
10. RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia. Lim JH; Jang S; Park CJ; Cho YU; Lee JH; Lee KH; Lee JO; Shin JY; Kim JI; Huh J; Seo EJ Cancer Genet; 2014; 207(1-2):40-5. PubMed ID: 24613277 [TBL] [Abstract][Full Text] [Related]
11. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Panagopoulos I; Nilsson T; Domanski HA; Isaksson M; Lindblom P; Mertens F; Mandahl N Int J Cancer; 2006 Mar; 118(5):1181-6. PubMed ID: 16161041 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. Nobusawa S; Hirato J; Yokoo H Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241 [TBL] [Abstract][Full Text] [Related]
13. EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR. Wu SG; Kuo YW; Chang YL; Shih JY; Chen YH; Tsai MF; Yu CJ; Yang CH; Yang PC J Thorac Oncol; 2012 Jan; 7(1):98-104. PubMed ID: 22124476 [TBL] [Abstract][Full Text] [Related]
14. Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas. Panagopoulos I; Gorunova L; Lund-Iversen M; Lobmaier I; Bjerkehagen B; Heim S Mod Pathol; 2016 Nov; 29(11):1415-1423. PubMed ID: 27469327 [TBL] [Abstract][Full Text] [Related]
15. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156 [TBL] [Abstract][Full Text] [Related]
16. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma. Hong M; Kim RN; Song JY; Choi SJ; Oh E; Lira ME; Mao M; Takeuchi K; Han J; Kim J; Choi YL J Thorac Oncol; 2014 Mar; 9(3):419-22. PubMed ID: 24518094 [TBL] [Abstract][Full Text] [Related]